133 related articles for article (PubMed ID: 24139022)
1. Longitudinal in vivo muscle function analysis of the DMSXL mouse model of myotonic dystrophy type 1.
Decostre V; Vignaud A; Matot B; Huguet A; Ledoux I; Bertil E; Gjata B; Carlier PG; Gourdon G; Hogrel JY
Neuromuscul Disord; 2013 Dec; 23(12):1016-25. PubMed ID: 24139022
[TBL] [Abstract][Full Text] [Related]
2. Peripheral neuropathy is linked to a severe form of myotonic dystrophy in transgenic mice.
Panaite PA; Kielar M; Kraftsik R; Gourdon G; Kuntzer T; Barakat-Walter I
J Neuropathol Exp Neurol; 2011 Aug; 70(8):678-85. PubMed ID: 21760538
[TBL] [Abstract][Full Text] [Related]
3. Respiratory failure in a mouse model of myotonic dystrophy does not correlate with the CTG repeat length.
Panaite PA; Kuntzer T; Gourdon G; Barakat-Walter I
Respir Physiol Neurobiol; 2013 Oct; 189(1):22-6. PubMed ID: 23811192
[TBL] [Abstract][Full Text] [Related]
4. Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy.
Reddy S; Smith DB; Rich MM; Leferovich JM; Reilly P; Davis BM; Tran K; Rayburn H; Bronson R; Cros D; Balice-Gordon RJ; Housman D
Nat Genet; 1996 Jul; 13(3):325-35. PubMed ID: 8673132
[TBL] [Abstract][Full Text] [Related]
5. Molecular, physiological, and motor performance defects in DMSXL mice carrying >1,000 CTG repeats from the human DM1 locus.
Huguet A; Medja F; Nicole A; Vignaud A; Guiraud-Dogan C; Ferry A; Decostre V; Hogrel JY; Metzger F; Hoeflich A; Baraibar M; Gomes-Pereira M; Puymirat J; Bassez G; Furling D; Munnich A; Gourdon G
PLoS Genet; 2012; 8(11):e1003043. PubMed ID: 23209425
[TBL] [Abstract][Full Text] [Related]
6. Progressive skeletal muscle weakness in transgenic mice expressing CTG expansions is associated with the activation of the ubiquitin-proteasome pathway.
Vignaud A; Ferry A; Huguet A; Baraibar M; Trollet C; Hyzewicz J; Butler-Browne G; Puymirat J; Gourdon G; Furling D
Neuromuscul Disord; 2010 May; 20(5):319-25. PubMed ID: 20346670
[TBL] [Abstract][Full Text] [Related]
7. Differential susceptibility of muscles to myotonia and force impairment in a mouse model of myotonic dystrophy.
Moyer M; Berger DS; Ladd AN; Van Lunteren E
Muscle Nerve; 2011 Jun; 43(6):818-27. PubMed ID: 21404300
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Delivery of Ligand-Conjugated Antisense Oligonucleotides (C16-HA-ASO) Targeting Dystrophia Myotonica Protein Kinase Transcripts for the Treatment of Myotonic Dystrophy Type 1.
Ait Benichou S; Jauvin D; De Serres-Bérard T; Bennett F; Rigo F; Gourdon G; Boutjdir M; Chahine M; Puymirat J
Hum Gene Ther; 2022 Aug; 33(15-16):810-820. PubMed ID: 35794764
[TBL] [Abstract][Full Text] [Related]
9. Congenital myotonic dystrophy: variability in muscle involvement and histopathological process.
Kuo HC; Huang CC; Chu CC; Wai YY; Hsiao KM; Chu NS
Acta Neurol Taiwan; 2006 Mar; 15(1):13-20. PubMed ID: 16599279
[TBL] [Abstract][Full Text] [Related]
10. Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice.
Jansen G; Groenen PJ; Bächner D; Jap PH; Coerwinkel M; Oerlemans F; van den Broek W; Gohlsch B; Pette D; Plomp JJ; Molenaar PC; Nederhoff MG; van Echteld CJ; Dekker M; Berns A; Hameister H; Wieringa B
Nat Genet; 1996 Jul; 13(3):316-24. PubMed ID: 8673131
[TBL] [Abstract][Full Text] [Related]
11. Myotonic dystrophy type 1 (DM1): a triplet repeat expansion disorder.
Kumar A; Agarwal S; Agarwal D; Phadke SR
Gene; 2013 Jun; 522(2):226-30. PubMed ID: 23570879
[TBL] [Abstract][Full Text] [Related]
12. [From gene to disease; altered RNA processing as a cause of myotonic dystrophy type 1].
de Die-Smulders CE; Faber CG; Smeets HJ
Ned Tijdschr Geneeskd; 2005 Sep; 149(37):2043-6. PubMed ID: 16184945
[TBL] [Abstract][Full Text] [Related]
13. Functional and histopathological identification of the respiratory failure in a DMSXL transgenic mouse model of myotonic dystrophy.
Panaite PA; Kuntzer T; Gourdon G; Lobrinus JA; Barakat-Walter I
Dis Model Mech; 2013 May; 6(3):622-31. PubMed ID: 23180777
[TBL] [Abstract][Full Text] [Related]
14. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
[TBL] [Abstract][Full Text] [Related]
15. [Effects of CTG repeat expansion on quantitative muscle histopathology in myotonic dystrophy].
Utsugisawa K; Yamagata M; Nagane Y; Tohgi H
Nihon Rinsho; 1997 Dec; 55(12):3214-8. PubMed ID: 9436439
[TBL] [Abstract][Full Text] [Related]
16. [A case of myotonic dystrophy showing proximal dominant muscle involvement but not myotonia].
Mihori A; Miyauchi H; Kaneda K; Nakayama M; Ono S; Shimizu N
Rinsho Shinkeigaku; 1999 Apr; 39(4):461-4. PubMed ID: 10391974
[TBL] [Abstract][Full Text] [Related]
17. Satellite cell dysfunction contributes to the progressive muscle atrophy in myotonic dystrophy type 1.
Thornell LE; Lindstöm M; Renault V; Klein A; Mouly V; Ansved T; Butler-Browne G; Furling D
Neuropathol Appl Neurobiol; 2009 Dec; 35(6):603-13. PubMed ID: 19207265
[TBL] [Abstract][Full Text] [Related]
18. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy.
Mankodi A; Takahashi MP; Jiang H; Beck CL; Bowers WJ; Moxley RT; Cannon SC; Thornton CA
Mol Cell; 2002 Jul; 10(1):35-44. PubMed ID: 12150905
[TBL] [Abstract][Full Text] [Related]
19. Myotonic dystrophy with no trinucleotide repeat expansion.
Thornton CA; Griggs RC; Moxley RT
Ann Neurol; 1994 Mar; 35(3):269-72. PubMed ID: 8122879
[TBL] [Abstract][Full Text] [Related]
20. Muscle phenotype in patients with myotonic dystrophy type 1.
Andersen G; Ørngreen MC; Preisler N; Colding-Jørgensen E; Clausen T; Duno M; Jeppesen TD; Vissing J
Muscle Nerve; 2013 Mar; 47(3):409-15. PubMed ID: 23169601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
